Clinical Trial Update: Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections [Phase 3]

View source ↗

Summary

Phase 3 trial of Anaferon for Children liquid formulation assessing efficacy and safety in acute upper respiratory infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Infections

Drugs mentioned

• Anaferon for Children (liquid dosage form)

Snippet

Sponsor: Materia Medica Holding | Conditions: Acute Upper Respiratory Infections | Phase 3 | Status: COMPLETED | Results posted: 2018-08-03